ProPhase Labs Files 8-K on Financials

Ticker: PRPH · Form: 8-K · Filed: Mar 31, 2025 · CIK: 868278

Prophase Labs, INC. 8-K Filing Summary
FieldDetail
CompanyProphase Labs, INC. (PRPH)
Form Type8-K
Filed DateMar 31, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-K, pharmaceuticals

TL;DR

ProPhase Labs dropped an 8-K detailing their financial condition on 3/31/25.

AI Summary

ProPhase Labs, Inc. filed an 8-K on March 31, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits, and a Regulation FD disclosure. The company, formerly known as Quigley Corp, is incorporated in Delaware and operates in the pharmaceutical preparations industry.

Why It Matters

This 8-K filing provides investors with crucial updates on ProPhase Labs' financial performance and operational status as of March 31, 2025.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial information and does not indicate any unusual or significant events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for ProPhase Labs, Inc.?

The primary purpose of this 8-K filing is to report on ProPhase Labs, Inc.'s results of operations and financial condition, as well as to include financial statements and exhibits and a Regulation FD disclosure.

When was this 8-K report filed by ProPhase Labs, Inc.?

This 8-K report was filed on March 31, 2025.

What was ProPhase Labs, Inc. formerly known as?

ProPhase Labs, Inc. was formerly known as Quigley Corp.

In which state is ProPhase Labs, Inc. incorporated?

ProPhase Labs, Inc. is incorporated in Delaware.

What is the Standard Industrial Classification (SIC) code for ProPhase Labs, Inc. and what does it represent?

The SIC code for ProPhase Labs, Inc. is 2834, which represents Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding ProPhase Labs, Inc. (PRPH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing